Table 1. Patient and Baseline Imaging Characteristics and Process Measures.
| Characteristic | No. (%) | |
|---|---|---|
| rFVIIa (n = 32) | Placebo (n = 37) | |
| Age, mean (SD), y | 70.7 (13.7) | 66.7 (12.4) |
| Male | 15 (47) | 20 (54) |
| White | 21 (66) | 20 (54) |
| Hypertension | 23 (72) | 26 (70) |
| Diabetes | 8 (25) | 5 (14) |
| Preadmission antiplatelet use | 8 (25) | 7 (19) |
| Systolic blood pressure, mean (SD), mm Hg | 159.9 (28.9) | 167.2 (27.5) |
| GCS score, median (IQR) | 14 (14-15) | 13 (12-15) |
| NIHSS score, median (IQR) | 16.0 (11.0-18.5) | 16.0 (13.0-20.0) |
| ICH volume, median (IQR), mL | 16.3 (9.6-39.2) | 20.4 (8.6-32.6) |
| IVH present | 14 (44) | 14 (38) |
| IVH volume, median (IQR), mL | 9.8 (5.5-14.7) | 11.8 (3.7-16.7) |
| ICH plus IVH volume, median (IQR), mL | 23.8 (15.3-40.0) | 24.5 (9.6-46.2) |
| Stroke onset to CT, median (IQR), min | 89 (71-187) | 83 (66-153) |
| Stroke onset to CT angiography, median (IQR), min | 106 (77-188) | 94 (78-162) |
| CT to study drug administration, median (IQR), min | 79 (61-99) | 64 (56-86) |
| Stroke onset to study drug administration, median (IQR), min | 195 (157-266) | 161 (137-224) |
| Treatment less than 3 h from onset | 9 (37) | 24 (65) |
Abbreviations: CT, computed tomography; GCS, Glasgow Coma Scale; ICH, intracerebral hemorrhage; IQR, interquartile range; IVH, intraventricular hemorrhage; NIHSS, National Institutes of Health Stroke Scale; rFVIIa, recombinant activated coagulation factor VII.